Loading...

Qingfei Jiang

Title(s)Asst Professor, Medicine
SchoolHealth Sciences
Phone858-246-5089
ORCID ORCID Icon0000-0002-9072-8032 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Diego, San Diego, CAPostdoctoral Fellowship01/2015Stem Cell
    University of Southern California, Los Angeles, CAPh.D12/2009Chemistry
    Hope College, Holland, MIB.S.08/2003Biology and Biochemistry
    United World Collage of Adriatic, ItalyI.B.01/2000
    Collapse Awards and Honors
    National Cancer Institute2019  - 2022K22 Career Development grant
    California Institute for Regenerative Medicine2011  - 2013Training Fellowship Interdisciplinary Stem Cell Training Program II

    Collapse Research 
    Collapse Research Activities and Funding
    Investigating the role of epitranscriptomic A-to-I RNA editing in T-cell acute lymphoblastic leukemia
    NIH K22CA229606Sep 1, 2019 - Aug 31, 2022
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Jiang Q, Diep R, Jamieson C. A-to-I RNA editing in leukemia stem cells - set ADAR1 on the radar. Oncotarget. 2019 Oct 22; 10(58):6047-6048. PMID: 31692993.
      View in: PubMed
    2. Jiang Q, Isquith J, Zipeto MA, Diep RH, Pham J, Delos Santos N, Reynoso E, Chau J, Leu H, Lazzari E, Melese E, Ma W, Fang R, Minden M, Morris S, Ren B, Pineda G, Holm F, Jamieson C. Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation. Cancer Cell. 2019 01 14; 35(1):81-94.e7. PMID: 30612940.
      View in: PubMed
    3. Jiang Q, Jamieson C. BET'ing on Dual JAK/BET Inhibition as a Therapeutic Strategy for Myeloproliferative Neoplasms. Cancer Cell. 2018 01 08; 33(1):3-5. PMID: 29316431.
      View in: PubMed
    4. Lazzari E, Mondala PK, Santos ND, Miller AC, Pineda G, Jiang Q, Leu H, Ali SA, Ganesan AP, Wu CN, Costello C, Minden M, Chiaramonte R, Stewart AK, Crews LA, Jamieson CHM. Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma. Nat Commun. 2017 12 04; 8(1):1922. PMID: 29203771.
      View in: PubMed
    5. Jiang Q, Crews LA, Holm F, Jamieson CHM. RNA editing-dependent epitranscriptome diversity in cancer stem cells. Nat Rev Cancer. 2017 06; 17(6):381-392. PMID: 28416802.
      View in: PubMed
    6. Zipeto MA, Court AC, Sadarangani A, Delos Santos NP, Balaian L, Chun HJ, Pineda G, Morris SR, Mason CN, Geron I, Barrett C, Goff DJ, Wall R, Pellecchia M, Minden M, Frazer KA, Marra MA, Crews LA, Jiang Q, Jamieson CHM. ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. Cell Stem Cell. 2016 08 04; 19(2):177-191. PMID: 27292188.
      View in: PubMed
    7. Crews LA, Jiang Q, Zipeto MA, Lazzari E, Court AC, Ali S, Barrett CL, Frazer KA, Jamieson CH. An RNA editing fingerprint of cancer stem cell reprogramming. J Transl Med. 2015 Feb 12; 13:52. PMID: 25889244.
      View in: PubMed
    8. Jiang Q, Crews LA, Barrett CL, Chun HJ, Court AC, Isquith JM, Zipeto MA, Goff DJ, Minden M, Sadarangani A, Rusert JM, Dao KH, Morris SR, Goldstein LS, Marra MA, Frazer KA, Jamieson CH. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2013 Jan 15; 110(3):1041-6. PMID: 23275297.
      View in: PubMed
    9. Ma W, Gutierrez A, Goff DJ, Geron I, Sadarangani A, Jamieson CA, Court AC, Shih AY, Jiang Q, Wu CC, Li K, Smith KM, Crews LA, Gibson NW, Deichaite I, Morris SR, Wei P, Carson DA, Look AT, Jamieson CH. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches. PLoS One. 2012; 7(6):e39725. PMID: 22768113.
      View in: PubMed